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ABSTRACT A panel of 146 monoclonal antibodies (MAbs),
obtained with Drosophila melanogaster tissue as primary immu-
nogen, was tested for cross-reactivity with the human central ner-
vous system. Sites examined included spinal cord, cerebellum,
hippocampus, and optic nerve. Nonnervous tissues tested were
liver and lymph node. Approximately half of the antibodies re-
acted with one or more sites in the human central nervous system,
identifying regional, cell class, and subcellular antigens. Some
recognized neuronal, glial, or axonal subsets. Immunoblot anal-
ysis revealed that some antibodies reacted with similar antigen
patterns in both species.
Although much of the neuronal network of the human central
nervous system has been mapped by classical histologic and
electrophysiologic methods, our knowledge of molecular dif-
ferences between functional cellular subsets is limited. A re-
markable tool, the monoclonal antibody (MAb), provides a new
dimension to neuroanatomy. This technique has begun to re-
veal, in the central nervous system of various organisms, hith-
erto unsuspected subsystems identifiable by their molecular
specificities (1-4). Although there has been some application
of MAbs to the human central nervous system, only a few sur-
veys of human neural antigens have been reported (5-8), partly
due to the difficulty of obtaining appropriate tissues and the
complexity of the structure.
Using a panel of 146 MAbs, originally isolated by Fujita et
al. (9) for a study of the Drosophila melanogaster nervous sys-
tem, we tested for reactions with the human central nervous
system. A surprisingly large number of cross-reactions showing
a wide variety of specificities was observed. In addition to pro-
viding new markers for the human nervous system, the mo-
lecular characteristics of these antigens are of interest in re-
spect to their evolutionary conservation and their possible roles
in development, behavior, and disease.
MATERIALS AND METHODS
Generation of MAbs. The mouse hybridomas were gener-
ated by using Drosophila melanogaster head, brain, or retina
homogenates as immunogens, fusing spleen cells with NS-1
myeloma cells, and cloning by limiting dilution. Supernatant
fluids were screened on frozen sections of fly heads by indirect
immunofluorescence microscopy (9).
Immunohistochemistry. Fresh human central nervous sys-
tem tissue was obtained postmortem from four patients, age
21-42 years, with no known neurological diseases. Samples were
dissected from spinal cord, optic nerve, hippocampus, cere-
bellum, lymph node, and liver. Blocks of approximately 1 cm3
were rapidly frozen in isopentane chilled with liquid nitrogen
and stored at -90'C. Cryostat sections (8 ,um) were placed on
multiwell slides (Roboz, South Pasadena, CA) and stored at
-20'C for 1 week or less. Staining was at room temperature.
Each section was covered with 50MA of hybridoma supernatant
diluted 1:3 with phosphate-buffered saline (Pi/NaCl: 0.26 M
KCl/0.14 M NaCl/0.25 M Na2HPO4/0.15 I KH2PO4, pH 7.4)
in a humidified chamber for 30 min, rinsed twice for 5 min in
Pi/NaCl, and incubated 15 min with 50-100 Al of fluorescein
isothiocyanate-conjugated goat anti-mouse IgG (heavyvand light
chains) (Cappel Laboratories, Cochranville, PA) diluted 1:50
with Pi/NaCl. After a final 5-min rinse in Pi/NaCl, the sections
were coverslipped with 90% (vol/vol) glycerol in Pi/NaCl, con-
taining paraphenvlenediamine (1 mg/ml) to reduce bleaching
(10), and were viewed with a Zeiss epifluorescence microscope.
Immunoblots. Tissue homogenates in gel electrophoresis
sample buffer [2.3% sodium dodecyl sulfate/5% mercaptoeth-
anol/63 mM Tris-HCl, pH 6.8/10% (vol/vol) glycerol] were
prepared in a Dounce glass homogenizer. For each gel, the
sample was either human central nervous system tissue (18 mg
of protein in 200 pl of sample buffer) or 60 fly heads (6 mg of
protein) in 100 pl of sample buffer. The samples were elec-
trophoresed in 10% polvacrylamide gel in Tris/glycine buffer
(11). The gels were electroblotted to nitrocellulose paper with
192 mM glycine/25 mM Tris base/20% methanol (12). Strips
(3-mm wide) were cut and incubated overnight at room tem-
perature with 3 ml of 1% bovine serum albumin (Sigma, RIA
grade) in buffer A (0.15 M NaCl/10 mM Tris-HCl, pH 7.4/
0.025% Nonidet P-40). Each strip was rinsed with buffer A and
incubated overnight at 220C with 1 ml of a hybridoma super-
natant diluted to 3 ml with buffer A, washed three times with
buffer A, and incubated for 2 hr with 3 ml of buffer A containing
9 x 10 cpm per strip of "NI-labeled sheep antimouse IgG (heavy
and light chains) (Amersham; specific activity, 5 ,gCi/gg; 1 Ci
= 37 GBq). The strips were washed three times with buffer A
and once with distilled water, air dried, and autoradiographed.
RESULTS
Tissue Specificities of MAbs. Many of the hybridoma clones
obtained with Drosophila tissue as primary immunogen pro-
duced MAbs that were cross-reactive with the human central
nervous system. Of 146 MAbs tested, 69 showed immunoflu-
orescent staining in one or more of the human nervous system
sites tested. Tissue samples from three or more different in-
dividuals were tested for each site and for each MAb and gave
consistent results. Table 1 shows the number of positive re-
actions for each central nervous system region. Many of the
MAbs stained comparable structures in all regions, while some
were specific to one.
Abbreviation: MAbs, monoclonal antibodies.
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FIG. 1. Spinal cord: motor neurons of the anterior horn. (A) Cross section through normal thoracic cord (Bodian stain). Enclosure indicates re-
gion in subsequent micrographs. (Bar = 200 akm.) (B) Typical anterior horn cell, as seen by phase microscopy. (C) MAb 6B5 shows prominent staining
at cytoplasmic membrane of perikaryon of anterior horn cell (arrows). (D) MAb 13H11 reacts with cytoplasm of anterior horn cell. (E) MAb 3G12
stains neuropil, but perikarya of motor neurons (arrows) are unstained. (F) MAb D12B reacts with fibrillar material within the perikaryon and
also the adjacent neuropil. (Bars in B-F = 20 ,tm.) Bright yellow stain in this and other figures is autofluorescence of cytoplasmic lipofuchsin.
FIG. 2. Spinal cord: dorsal column nerve tracts. (A) Enclosure indicates region examined. (Bar = 200 um.) (B) Phase micrograph shows cross
section through axons of varying diameters. Myelin appears dark. (C) MAb 3F12 stains central regions of axons. (D) MAb6B5 stains concentric
circles, apparently axonal membranes and myelin sheath peripheries. Larger axons stain more intensely. (E) With MAb 8C3, myelin sheaths appear
unstained, whereas axonal membranes are stained. (F) MAb 3G12 reacts with matrix between nerve fibers, but fibers themselves are unstained.
(Bars in B-F = 20 gm.)
FIG. 3 (on nextpage). Cerebellar cortex. In immunofluorescence micrographs, internal granule cell layer is to the left, molecular layer is to the
right. Arrows indicate Purkinje cells. (A) MAb G12 shows a Purkinje cell enwrapped with processes characteristic of basket fibers. (B) With MAb
23H2, Purkinje cell and internal granule cells are outlinedby punctate halos. (C) MAb 8C3 reacts with neuropil only. Neuronal perikarya ofPurkinje
and internal granule neurons are unstained. (D) MAb 1OG4 stains Purkinje cell cytoplasm but not nucleus. (E) MAb 3F7 selectively stains nuclei
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FIG. 4. Hippocampus. (A) Section at the level of the lateral geniculate nucleus, showing small neurons of the dentate gyrus, and pyramidal
cells. Luxol fast blue/cresyl violet stain. Immunofluorescence microscopy is on the area designated by enclosure. (Bar = 200 Atm.) (B) MAb 8C5
stains all nuclei, illustrating cells of dentate gyrus. (C) MAb 2F12 selectively stains neurons of the dentate gyrus. (D) Mub 10G9 stains neuropil
but not the dentate gyrus cells. (E) MAb 6E1 stains a stellate cell. (F7) MAb 3F12 stains pyramidal neurons and their processes. (Bars in B-F = 20
,am.) Cytoplasm in cells of C and F contains lipofuchsin (yellow) in addition to antigen.
FIG. 5. Gial and vasulalr specificity-. Sectionthriouh spinalcord shows selpetive stainingaof small arteries (MAb'3H3.) (A) andep-endyma and
subependyma of central canal area (MAb 12D12) (B). (C) Cerebellar cortex is traversed by fibrils characteristic ofBergman's astrocytes (MAb 14F5).
(Bars = 100 Am.)
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A wide diversity of staining patterns was observed, with rel-
atively little redundancy. Antigens were often specific to one
cell class or subcellular component. Sixteen MAbs showed dis-
tinct staining of portions of neurons. Four MAbs reacted strongly
with neuropil but did not stain neuronal cell bodies, and four
stained axons alone. In addition, five MAbs stained cell nuclei
in all tissues examined. One MAb (12E4) was specific to the
membranes of neuronal cell nuclei.
Fig. 1 shows examples of motor neurons staining in the an-
terior horn of the spinal cord. MAb 6B5 selectively stained fo-
cal areas on the motor neuron plasma membrane, possibly
identifying synaptic terminals on the perikaryon. MAb 13H11
stained the cytoplasm of the neuron, whereas MAb 3G12 was
positive for the neuropil, leaving the perikarya as "black holes."
MAb D12B reacted with both neuropil and perikaryon.
Microscopic detail of axonal staining was observed in trans-
verse sections of the dorsal column of the spinal cord (Fig. 2).
Various MAbs distinguished among the components of the ax-
ons and their myelin sheaths. MAb 3G12 stained the matrix
between nerve fibers, leaving the fibers themselves unstained.
Subcellular staining differences also could be defined within
the cerebellum. An antigenic dissection of the Purkinje cell is
illustrated in Fig. 3. MAb G12 revealed processes enwrapping
the cell in a pattern characteristic of basket fibers. MAb 23H2
outlined the Purkinje cells (and also the internal granule cells)
with punctate halos. MAb 10G4 stained cytoplasm, but not nu-
cleus; MAb 3F7 stained nucleus, but not nucleolus. MAb 12E4
stained only the nuclear membranes of the Purkinje cells (and
also internal granule cells). An example of negative specificity
was shown by MAb 8C3, which stained neuropil, the neuronal
perikarya appearing as blank areas.
Fig. 4 illustrates specificity within the hippocampus. The
various MAbs stained neurons of the dentate gyrus, pyramidal
neurons and their processes, stellate cells, nuclei, or neuropil.
Eight MAbs showed specificity for cells judged to be astro-
cytes by their shapes and locations in phase-contrast and he-
matoxylin/eosin-stained sections. Three other MAbs stained
apparent oligodendrocytes. Verification of cell class will re-
quire immunoperoxidase localization with known molecular
markers, such as anti-glial fibrillary acidic protein for astro-
cytes, anti-myelin basic protein and ,3galactocerebroside for
oligodendroglia. As seen in Fig. 5A, MAb 14F5 revealed fi-
brillar processes characteristic of the infrastructure of Berg-
man's astrocytes in the cerebellum. Fig. 5B shows the sub-
ependymal astroglial matrix and ependymal cells stained by MAb
12D12.
Two MAbs reacted exclusively with blood vessels [e.g., MAb
3H3 (Fig. 5C)], which stained the entire vessel wall. Other an-
tibodies, although staining some nonvascular structures as well,
reacted with selected portions of the vascular wall, such as the
luminal surfaces of endothelial cells, the media, or the adven-
titia.
A large number of antibodies, not illustrated here, reacted
Table 1. Human central nervous system specificities of
monoclonal antibodies
MAbs tested
No. positive No. unique
Region Total no. for region to region
Spinal cord 146 46 2
Optic nerve 146 31 3
Hippocampus 146 41 7
Cerebellum 146 48 7
Lymph node 32 2 0
Liver 32 2 0
with various combinations of cell types. Important molecular
relationships between them may emerge when the antigens are
identified.
The majority of antibodies manifested strong specificity for
the nervous system. Thirty-two of the strongly neuroreactive
antibodies were selected to be tested on human liver and lymph
node. Only two were positive (Table 1). They stained cytoplasm
in both tissues. Another set of five MAbs that stained the cell
nuclei in all central nervous system tissues was also tested. They
stained liver and lymph node nuclei as well.
Immunoblot Analysis. Antigens identified by 23 neuroreac-
tive MAbs were examined. Some blots showed single bands
and others showed several bands or a continuum of radiola-
beled material, the latter suggestive of proteins modified by
lipid or carbohydrate groups. In some cases, the patterns for
Drosophila and human antigens showed close similarities. Fig.
6 shows three such pairs.
DISCUSSION
MAbs provide an incisive method for mapping the molecular
anatomy of the human nervous system. They can greatly ex-
tend the molecular repertoire beyond the relatively limited
number of known neuro-specific markers. Unlike conventional
histological stains, where the molecular specificity may be elu-
sive, MAbs can be used to purify and identify the antigens.
The remarkably high degree of cross-reactivity between fly
and human brain and the occurrence of similar patterns on im-
munoblots suggests the possibility of evolutionary conservation
of many more central nervous system molecules than hitherto
known. The occurrence of a cross-reaction does not, by itself,
demonstrate homology in primary protein structure. In any
particular case, the MAb could be reacting with similar epi-
topes in otherwise quite different molecules. The epitopes could
be in protein, carbohydrate, or lipid moieties. This question
will be addressed by identifying the reactive group of the an-
tigen in each species and, where the protein moiety is involved,
by peptide analysis. It will be of interest to learn whether the
antibodies indeed identify molecules that are common to ner-
vous systems that have evolved so differently in the inverte-
brate and vertebrate branches.
Our results were surprising because, as a rule, MAbs show
narrower species range than do polyclonal antibodies. For in-
stance, polyclonal antibody to myelin basic protein cross-re-
acted with many mammalian species, whereas MAbs were spe-
cific for subgroups (13).
Cross-reactivity between vertebrate species has been doc-
umented. Using human central nervous system tissue as pri-
mary immunogen, McKenzie et al. (14) found a MAb, reactive
with a brain glycoprotein, that cross-reacted with the central
nervous system of rat, dog, and mouse but not of frog or chicken.
Barnstable (15) found MAbs to rat retina that cross-reacted with
tiger salamander retina. Others have shown MAb cross-reac-
tions of rat cerebellar antigens with central nervous system of
mouse, rabbit, sheep, pig, cow, and human (16, 17). Cross-
reactivity of a chicken central nervous system MAb with mouse,
rat, and rabbit has been identified (18). Using hamster central
nervous system tissue as primary immunogen, Franko et al. (5)
showed cross-reactivity with human central nervous system in
19 of 30 MAbs. Only 3 were neuron-specific in hamsters and
none in human.
All these cases of cross-reactivity involved vertebrates. Rel-
atively few comparisons have been made between species as
disparate as human and fly, perhaps because such homologies
were expected to be rare. Nevertheless, bizarre examples oc-
cur, such as a MAb to horseradish peroxidase showing a cross-
Proc. Natl. Acad. Sci. USA 80 (1983)
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FIG. 6. Immunoblot analysis of human and Drosophila antigens
using Drosophila MAbs. Homogenates of human spinal cord (columns
H) or Drosophila heads (columns D) were electrophoresed on polyacryl-
amide gels (10% for MAbs 8C3 and 10G9, 12% for MAb 3F12) and elec-
troblotted to nitrocellulose. The nitrocellulose was cut into strips and
each strip was stained with the specified MAb. Autoradiograms showed
binding of "25I-labeled second antibody. Molecular weight markers:
carbonic anhydrase, 30 kilodaltons (kDa); ovalbumin, 45 kDa; bovine
serum albumin, 67 kDa; Escherichia coli RNA polymerase ,l subunit,
160 kDa; jack bean urease, 240-kDa. For each MAb, human central ner-
vous system and Drosophila head samples were run simultaneously in
parallel gels.
reaction to Drosophila axons (19). Our results suggest that it
may be worthwhile to scan more boldly between species.
The immunofluorescence screening method, using sections,
is relatively rapid and sensitive. Detection of only a few re-
active cells is feasible, and the method provides a direct lo-
calization of the antigen in tissue. Other immunoassays, while
highly sensitive and appropriate to isolation and quantification
of antibodies to an already purified antigen, do not offer these
advantages for detecting unknown and possibly rare molecules
unique to specific structures.
One problem with human tissue is the postmortem delay in
obtaining samples; autolysis, with alteration of the antigens,
may occur. Whereas our experience with tissues obtained at 6,
12, and 18 hr postmortem indicated no major progressive loss
of the antigens observed, shorter postmortem intervals did re-
sult in greater preservation of cellular detail. A critical factor
was the "snap-freezing" in chilled isopentane. The results re-
ported were for unfixed cryostat sections. Formaldehyde fix-
ation eliminated the staining in all cases. Acetone, on the other
hand, had a less destructive effect, with some antigens retain-
ing their activity. Presumably, each antigen will have its own
optimal fixation procedure.
In various neurologic diseases, there is selective vulnera-
bility of certain neurons or glial cells. For example, in amyotro-
phic lateral sclerosis, motor neurons degenerate; in Hunting-
ton's disease, cells of the caudate nucleus deteriorate; in some
cases of Alzheimer's disease, cells in certain basal forebrain nu-
clei are lost (20). MAbs may be useful as tags for sorting of spe-
cific cell types to identify the molecular profiles of such se-
lectively vulnerable cells and to detect missing or novel antigens
in diseased tissue.
Many human neurological defects are hereditary, but prog-
ress in human disease has been stymied often by the lack of
model systems. Drosophila mutants also display hereditary
pathologies such as brain degeneration in the drop dead mutant
(21) and muscle defects resembling nemaline myopathy in the
wings-up mutant (22). With currently available recombinant DNA
technology, it may well be feasible to transfer a selected gene
from human to fly in order to study its function. Complications
in this procedure arise because, due to the existence of introns
and degeneracy in the genetic code, the DNA structures in each
organism may differ considerably, even if their protein prod-
ucts are closely homologous. Therefore, the molecular homol-
ogy revealed by a MAb could be crucial. In principle, it makes
possible the isolation of the mRNA from polysomes of each or-
ganism, hence, leading to cDNA probes for the isolation of their
respective genes.
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